Provan, W. McLean

Pharmacokinetics and pharmacodynamics of NTBC (2‐(2‐nitro‐4‐fluoromethylbenzoyl)‐1,3‐cyclohexanedione) and mesotrione, inhibitors of 4‐hydroxyphenyl pyruvate dioxygenase (HPPD) following a single dose to healthy male volunteers

Hall, M. G., Wilks, M. F., Provan, W. M., Eksborg, S., & Lumholtz, B. (2001) · British Journal of Clinical Pharmacology

Pharmacogenetics and Drug MetabolismPesticide Exposure and Toxicity

Cited by 110

Tyrosinemia produced by 2-(2-nitro-4-trifluoromethylbenzoyl)-cyclohexane-1,3-dione (NTBC) in experimental animals and its relationship to corneal injury

Lock, E. A., Gaskin, P., Ellis, M., Provan, W. M., & Smith, L. L. (2006) · Toxicology and Applied Pharmacology

Drug-Induced Ocular ToxicityPharmacogenetics and Drug Metabolism

Cited by 35